Heme biosynthesis by the malarial parasite import of &#948;-aminolevulinate dehydrase from the host red cell by Bonday, Zahid Q. et al.
Heme Biosynthesis by the Malarial Parasite
IMPORT OF d-AMINOLEVULINATE DEHYDRASE FROM THE HOST RED CELL*
(Received for publication, February 3, 1997, and in revised form, June 19, 1997)
Zahid Q. Bonday‡§, Shigeru Taketani¶, P. D. Guptai, and Govindarajan Padmanaban‡**‡‡
From the ‡Department of Biochemistry, Indian Institute of Science, Bangalore 560 012, India, ¶Kansai Medical
University, Fumizonocho Norwich Osaka 570, Japan, iCenter for Cellular and Molecular Biology, Hyderabad, 500 007,
India, and **Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore 560 064, India
The mouse and human malarial parasites, Plasmo-
dium berghei and Plasmodium falciparum, respectively,
synthesize heme de novo following the standard path-
way observed in animals despite the availability of large
amounts of heme, derived from red cell hemoglobin,
which is stored as hemozoin pigment. The enzymes,
d-aminolevulinate dehydrase (ALAD), coproporphyrino-
gen oxidase, and ferrochelatase are present at strikingly
high levels in the P. berghei infected mouse red cell in
vivo. The isolated parasite has low levels of ALAD and
the data clearly indicate it to be of red cell origin. The
purified enzyme preparations from the uninfected red
cell and the parasite are identical in kinetic properties,
subunit molecular weight, cross-reaction with antibod-
ies to the human enzyme, and N-terminal amino acid
sequence. Immunogold electron microscopy of the in-
fected culture indicates that the enzyme is present in-
side the parasite and, therefore, is not a contaminant.
The parasite derives functional ALAD from the host and
the enzyme binds specifically to isolated parasite mem-
brane in vitro, suggestive of the involvement of a recep-
tor in its translocation into the parasite. While, ALAD,
coproporphyrinogen oxidase, and ferrochelatase from
the parasite and the uninfected red cell supernatant
have identical subunit molecular weights on SDS-poly-
acrylamide gel electrophoresis and show immunological
cross-reaction with antibodies to the human enzymes, as
revealed by Western analysis, the first enzyme of the
pathway, namely, d-aminolevulinate synthase (ALAS) in
the parasite, unlike that of the red cell host, does not
cross-react with antibodies to the human enzyme. How-
ever, ALAS enzyme activity in the parasite is higher
than that of the infected red cell supernatant. We there-
fore conclude that the parasite, while making its own
ALAS, imports ALAD and perhaps most of the other
enzymes of the pathway from the host to synthesize
heme de novo, and this would enable it to segregate this
heme from the heme derived from red cell hemoglobin
degradation. ALAS of the parasite and the receptor(s)
involved in the translocation of the host enzymes into
the parasite would be unique drug targets.
Chloroquine resistance in malarial parasite is assuming se-
rious proportions, and the necessity to discover new drugs to
treat malaria is a major challenge. This calls for the identifi-
cation of newer drug targets.
Studies in this laboratory have revealed that the human
malarial parasite, Plasmodium falciparum, synthesizes heme
de novo. The parasite is able to incorporate [2-14C]glycine and
4-14C-labeled d-aminolevulinate (ALA),1 but not [1-14C]gluta-
mate into heme, indicating that the parasite manifests the
glycine pathway observed in liver and erythroids. ALA syn-
thase and ALA dehydrase activities were also detected in the
parasite (1). The synthesis of heme de novo by the parasite in
the intraerythrocytic stage is rather surprising, since the par-
asite obtains a surplus of heme from the degradation of the red
cell hemoglobin. However, this heme is stored as the inert
hemozoin pigment (2, 3). Further, most hemoflagellates, para-
sitic protozoa in both plants and animals, need preformed heme
for growth (4).
Leishmania tarentolae was found to contain free porphyrins
but required intact iron-protoporphyrin for growth in culture,
suggesting that it may lack ferrochelatase, the enzyme re-
quired to incorporate iron into protoporphyrin (5). Trypano-
some cruzi was shown to require hemin/hemoglobin for growth.
It was reported to manifest ALA dehydrase activity, but por-
phobilinogen deaminase was absent. However, functional fer-
rochelatase could be detected, leading to the conclusion that
the parasite has lost part of its heme pathway due to mutations
in some of the enzyme sequences, necessitating preformed he-
min requirement (6).
The malarial parasite contains cytochromes (7, 8), and stud-
ies in this laboratory have demonstrated a requirement for
heme to sustain optimal protein synthesis (9). De novo synthe-
sis of heme is vital to the malarial parasite, since treatment of
the culture with succinylacetone, a specific inhibitor of ALA
dehydrase, leads to death of the parasite. It has, therefore, been
concluded that the parasite utilizes the heme synthesized de
novo for metabolic purposes, whereas it stores the surplus
heme, which is toxic, derived from hemoglobin degradation as
inert hemozoin pigment (1, 9). In view of these results and the
possibility that the heme biosynthetic pathway of the malarial
parasite could be a new drug target, studies have been carried
out on the possible origin of the enzymes of the pathway. The
results indicate the interesting feature that the parasite ge-
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the parasite makes ALA synthase, the first enzyme of the
pathway, it imports ALA dehydrase and perhaps most of the
other enzymes of the pathway from the host red cell to acquire
the heme biosynthetic potential.
EXPERIMENTAL PROCEDURES
Materials
Antibodies raised against purified CPO and FC preparations from
the human red blood cells in rabbits (10) were used. Antibodies to
human red cell ALAS and full-length mouse erythroid ALAD clone were
kind gifts from Dr.Gloria C. Ferreira, University of South Florida and
Dr. Terry Bishop, Johns Hopkins University, respectively. [2-14C]Gly-
cine and 4-14C-labeled d-aminolevulinic acid were obtained from BRIT
(Bombay) and NEN Life Science, respectively.
Methods
Parasite Maintenance and Isolation—Swiss mice were injected with
P. berghei, and blood was removed at different stages of parasitemia
ranging from 30 to 80%. The parasitized red cells as well as the red cells
from uninfected mice (control) were spun down and put into overnight
culture as described for P. falciparum (11). In some experiments, P.
falciparum maintained on O1 human red blood cells in culture (about
8% parasitemia) as described earlier (1, 11) was also used. After appro-
priate treatment of culture, the cells were isolated and lysed with 0.15%
(w/v) saponin (12). The parasite pellet as well as the infected red cell
supernatant (IRS) were obtained by centrifugation. The red cells from
uninfected mice were processed similarly to isolate the uninfected red
cell supernatant (URS) and the membrane pellet.
Heme Synthesis by P. berghei in Culture—Mice were injected with P.
berghei and blood was removed at different stages of parasitemia rang-
ing from 30 to 80%. The parasitized as well as control red blood cells
were spun down and put into overnight culture (8 h), during which time
they were incubated with [4-14C]ALA (1 mCi) or [2-14C]Glycine (12.5
mCi). The red cells were pelleted, and the parasite pellet, IRS, and URS
were isolated after lysis. The fractions were extracted with ethyl ace-
tate/acetic acid (3:1). The extract was washed with water and then 1.5
N HCl to remove the precursor used and all the porphyrins. The final
ethyl acetate layer was washed twice with water to remove acid and
used to measure radioactivity incorporated into heme (13). Separate
analysis of the ethyl acetate layer by chromatography has revealed that
the radioactivity is entirely accounted for by heme (14). The first water
wash and the 1.5 N HCl-extracted fractions were used to analyze for
radioactivity in ALA plus porphobilinogen (PBG) and coproporphyrin
plus protoporphyrin, respectively (13). ALA and porphobilinogen were
separated by fractionation on a Dowex-1 (acetate) column (15).
Assay of Enzymes—ALAS, ALAD, and FC activities were assayed in
isolated fractions of the parasite, IRS, and URS. The parasite pellet was
lysed with 20 mM Tris-HCl (pH 7.5) containing 0.2% Triton X-100 by
repeated homogenization, and the membrane fraction was pelleted at
8000 3 g (15 min). This fraction was used to assay ALAS and FC, since
the activities were located in this fraction. The assay mixture for ALAS
contained the following (16): Tris, pH 7.5 (50 mM), glycine (100 mM),
sodium succinate (10 mM), MgCl2 (5 mM), coenzyme A (500 mM), ATP (5
mM), pyridoxal phosphate (200 mM), partially purified Escherichia coli
succinyl-CoA synthase (20 mg), and the membrane protein (100 mg). The
mixture was incubated for 1 h at 37 °C. The product was converted to
porphobilinogen by the addition of purified ALAD, and porphobilinogen
formed was estimated using modified Ehrlich reagent (17). FC was also
assayed in the membrane fraction (18), and the assay mixture con-
tained Tris, pH 7.5 (20 mM), protoporphyrin 1 X (100 mM), b-mercapto-
ethanol (1 mM), 59FeCl3 (2.5 mCi), and membrane protein (50 mg). The
mixture was incubated for 1 h at 37 °C under anaerobic conditions.
Radioactive heme formed was then extracted and radioactivity meas-
ured. ALAD was assayed in the soluble fractions after passing the same
through a DEAE-Sepharose column to remove hemoglobin. The enzyme
activity was located in the 0.2 M NaCl eluate, and the assay mixture
contained Tris, pH 7.5 (20 mM), ALA (50 mM), ZnCl2 (10 mM), b-mercap-
toethanol (5 mM), and enzyme fraction (20 mg of protein). The assay
mixture was incubated at 37 °C for 1 h. The porphobilinogen formed
was estimated using modified Ehrlich reagent (17).
Purification of ALAD from the Parasite (P. berghei) and RBCs—
ALAD was purified from the parasite pellet and mouse and human red
blood cells by a slight modification of the known procedure (19). The
parasite and red cell lysates were spun at 8000 3 g for 15 min, and the
soluble fractions were subjected to the following steps: DEAE-Sephacel
chromatography, ammonium sulfate fractionation (0–45%), and octyl-
Sepharose and phenyl-Sepharose chromatography. The last two column
steps were repeated with the preparation obtained to get the pure
protein. The preparation from human red blood cells was used to raise
antibodies in rabbits.
Western Blot Analysis—The purified ALAD preparations (75 ng)
from the parasite and mouse red blood cells were analyzed on SDS-
PAGE (10% gels) and transferred to nitrocellulose for immunoblot anal-
ysis. Similarly, membrane fractions (8000 3 g pellet, 100 mg of protein)
from the parasite, IRS, and URS were used for Western analysis of
ALAS, CPO, and FC. The crude soluble fraction (75 mg of protein) was
also used for analysis of ALAD. The blots were screened with antibodies
to the human enzyme preparations, diluted in the range 1:200 to
1:1000. The blots were finally analyzed with goat anti-rabbit antibodies
conjugated to alkaline phosphatase.
N-terminal Sequence Analysis—Purified ALAD from the parasite (P.
berghei) was subjected to N-terminal sequence analysis using a Shi-
madzu gas phase protein sequencer (PSQ1).
Immunogold Electron Microscopy—Immunogold electron microscopy
was carried out (20) with the isolated parasite (P. berghei), as well as
with the infected and uninfected red cells. These were fixed with 4%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, and embedded in
LR Gold resin. Sections (60–70 nm) were cut and picked on copper
grids. In experiments where purified ALAD was incubated with para-
site membrane to demonstrate binding, the membrane preparation was
first sonicated briefly to get a homogenous preparation. After incuba-
tion with ALAD and washing, the membrane pellet was diluted sever-
alfold and used directly for coating copper grids by incubating at room
temperature for 1 h. All of the grids were washed with PBS containing
3% bovine serum albumin and incubated for 2 h with ALAD antibodies
(1:1000 diluton), washed again, and then incubated with goat anti-
rabbit IgG conjugated to gold particles (10 nm in diameter) in PBS
containing 1% bovine serum albumin. The grids were stained with 2%
osmium tetroxide and examined under the electron microscope.
Influence of Succinylacetone Treatment of the Host Red Cell on ALAD
Activity of the Parasite (P. falciparum)—Succinylacetone is known to be
an irreversible inhibitor of ALAD activity (21). Fresh human RBCs (in
complete medium) were incubated with succinylacetone (500 mM in final
concentration) overnight at 4 °C. These as well as RBCs not treated
with succinylacetone (control) were washed thoroughly with culture
medium and then incubated with PBS containing 2 mM ALA for 2 h at
37 °C to remove any free succinylacetone by converting it nonenzymat-
ically to a pyrrole (22). A 3-day-old culture (1.5 ml) of P. falciparum was
subcultured in two vials, one receiving succinylacetone-treated RBCs
and the other control RBCs. After another 4 days, a second subculturing
was done with the respective RBCs. After another 48 h, the cultures
were incubated with 1 mCi of [4-14C]ALA overnight as described earlier.
Radioactivity incorporation into heme was measured in the parasite
and red cell supernatant fractions. In another experiment, several vials
were pooled after second subculturing, and ALAD activity was assayed
in the parasite and red cell supernatant fractions. To ensure that the
succinylacetone-treated RBCs used in culturing did not have any car-
ryover of free succinylacetone to inhibit ALAD activity, untreated and
succinylacetone-treated RBCs were lysed, and the enzyme activity was
assayed in each of the fractions as well as when they were mixed.
Specific Binding of Host Red Cell ALAD to the Parasite (P. berghei)
Membrane—The parasites were isolated from infected mouse red blood
cells by saponin lysis as described earlier. The parasites were then lysed
in 20 mM Tris-HCl buffer (pH 7.5) containing 0.2% Triton X-100 for 1 h
at 4 °C. The lysate was spun down at 12,000 3 g for 30 min, and the
pellet was washed with PBS. The membrane pellet was suspended in 20
mM Tris-HCl buffer (pH 7.5) containing 0.5% Triton X-100 and an
aliquot (200 mg of protein) was incubated with partially purified ALAD
from mouse RBCs at room temperature for 1 h with gentle shaking. A
similar incubation was carried out with mouse red cell membrane and
trypsin-treated, washed parasite membrane. Another control employed
was the incubation of bacterially expressed glutathione S-transferase
and glutathione S-transferase-retinoic acid X receptor fusion proteins
with the parasite membrane under similar conditions. After the incu-
bations, the membrane fractions were reisolated by centrifugation and
washed repeatedly with PBS, and the pellet was then subjected to
SDS-PAGE (10% gels) followed by Western analysis with anti-ALAD
and anti-fusion protein antibodies. In addition, the membrane fraction
was also examined through immunoelectron micrography as described
earlier.
Determination of the Number of Binding Sites for ALAD on the
Parasite Membrane—Full-length mouse erythroid ALAD-cDNA was
cloned and expressed with histidine tag in the T7 polymerase promoter
based vector, pRSETB. The transformed E. coli cells were grown in 5 ml
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of LB medium (inoculated from an overnight culture) and after 2 h of
growth (OD 0.6), 1 mM isopropyl-1-thio-b-D-galactopyranoside and 200
mCi of [35S]methionine were added. After another 21⁄2 h of incubation,
labeled ALAD was isolated from E. coli cells and purified on a nickel-
nitrolotriacetic acid (Qiagen) column, using a single-step affinity pro-
cedure. The parasite membrane (2.4 mg of protein) was solubilized
using 2.5% Triton X-100, 0.5% sodium cholate, and 0.5 M NaCl for
suspension followed by sonication. The insoluble debris was removed by
centrifugation, and the solubilized membrane was loaded onto nitrocel-
lulose membrane filters. These filters were then blocked with 5%
skimmed milk powder in TTBS (0.1% Triton X-100, 50 mM Tris-buff-
ered saline) containing 1% bovine serum albumin. The nitrocellulose
membrane was then incubated with increasing amounts of labeled
ALAD for 1 h in the presence and absence of a 100-fold excess of
nonradioactive ALAD. The nitrocellulose membrane filters were
washed thrice with TTBS and dried, and radioactivity was measured.
The data were used to generate the saturation curve and the Scatchard
plot to calculate the dissociation constant and the number of binding
sites.
RESULTS
De Novo Heme Synthesis in P. berghei and P. falciparum—In
the case of P. berghei, blood from infected and uninfected mice
was spun down, and the cells were incubated with [2-14C]gly-
cine or [4-14C]ALA for 8 h in culture. In the case of P. falcipa-
rum, the parasite maintained in culture was incubated with
the radiolabeled precursors overnight. The cells were then
pelleted down, washed, and lysed with saponin, and the para-
site pellet, IRS, and URS were used for measurement of radio-
activity in the heme fraction. The results presented in Fig. 1 (A
and B) indicate that similar results are obtained with P.
berghei and P. falciparum. The parasite-infected red cell syn-
thesizes 5–8-fold more heme than the uninfected red cell.
Certain interesting features of the incorporation pattern of the
precursors into heme are also evident. With [4-14C]ALA as
precursor, 80% of the radioactive heme is recovered in IRS,
whereas with [2-14C]glycine as precursor, the bulk of the ra-
dioactive heme is recovered in the parasite pellet.
Next, it was of interest to examine the heme biosynthetic
potential of the isolated fractions. These experiments were
carried out with P. berghei, since high yields of the parasite
could be obtained from infected mice. The IRS, URS, and the
parasite pellet were individually incubated with [4-14C]ALA,
and the incorporation of radioactivity into heme and interme-
diates of the pathway was measured. The results presented in
Table I indicate certain interesting features. First, maximum
heme synthesis is again seen in IRS that is ; 4–5-fold more
than URS or parasite pellet. The parasite pellet has a substan-
tial amount of [4-14C]ALA remaining unutilized compared with
URS or IRS. This correlates with the low levels of ALAD
detected in P. berghei (this study) as well as in P. falciparum
(1). Nevertheless, the parasite converts the porphyrin interme-
diates to heme efficiently and is more effective than the URS.
This suggests that FC, catalyzing iron incorporation into pro-
toporphyrin, could be present at significant levels in the
parasite.
Assay of Heme Biosynthetic Enzymes in P. berghei—The next
step was to assay the activities of ALAS, ALAD, and FC in P.
berghei and mouse IRS and URS fractions. ALAS and FC
activities were detected in the 8000 3 g pellet in each case,
whereas ALAD activity was detected in the soluble fractions.
The results presented in Table II indicate that ALAS activity in
the parasite is 3–4-fold more than in IRS or URS. FC activity
in the parasite is as high as that in IRS and is 9–10-fold more
than in URS. ALAD activity in the parasite is ;20-fold lower
than IRS and 4–5-fold lower than in URS. From the results
presented, it is also clear that, whereas the activity of ALAS is
the same in infected and uninfected RBC preparations, the
activities of ALAD and FC are at least 5-fold greater in IRS
than in URS.
Parasite and Red Cell ALAD Activities Are Due to the Same
Protein Species—ALAD was purified to homogeneity from P.
berghei (Fig. 2), mouse and human red blood cells. The human
FIG. 1. Heme synthesis by P. falciparum and P. berghei in culture. P. berghei-infected and -uninfected mouse red blood cells were spun
down and put into overnight culture in microtiter plates. P. falciparum was maintained in culture in O1 red blood cells. The cultures were
incubated with [4-14C]ALA (1 mCi) or [2-14C]glycine (12.5 mCi) for 8 h in the case of P. berghei and 12 h in the case of P. falciparum. The red cells
were pelleted, and the parasite, IRS, and URS were isolated. The fractions were extracted with ethyl acetate/acetic acid (3:1), and radioactivity
incorporated into heme in the ethyl acetate layer was measured after the appropriate washes (13).
TABLE I
Synthesis of heme by isolated fractions from infected (P. berghei) and
uninfected red cells in vitro
Infected or uninfected blood was spun down, pelleted red cells were
lysed, and the washed parasite pellet (P), IRS, and URS were incubated
with 1 mCi of [4-14C]ALA for 8 h. The various intermediates were
isolated (13), and radioactivity was measured. The results presented
are those obtained in a typical experiment.
Metabolites
Radioactivity incorporated
P IRS URS
cpm/4 3 108 cells
ALA (unutilized) 499,950 55,000 62,000
PBG 141,400 37,000 24,000
CPP plus PRPa 250,000 177,000 790,000
Heme 193,000 755,000 125,000
a Coproporphyrin plus protoporphyrin.
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enzyme preparation was used to raise antibodies in rabbits.
The parasite and mouse red cell (uninfected) enzymes appear
identical on the basis of several criteria. Both of the purified
preparations show a Km of about 1.5 3 10
24 M for ALA. They
exhibit a broad pH optimum with a peak at about 7.2. Both
preparations show a requirement for zinc. Succinylacetone at a
concentration of 50 mM brings about 50% inhibition of the
activities of both of the enzyme preparations. Both enzyme
species have identical subunit molecular mass (;37 kDa) on
SDS-PAGE and cross-react equally well with antibodies to the
human enzyme (Fig. 3A). The N-terminal 20-amino acid se-
quence of both of the preparations is identical (Fig. 3B). In view
of the fact that ALAD preparation from humans and mice differ
by as many as 3 amino acids and are totally different between
mice and yeast in this stretch (23), it has to be concluded that
the P. berghei and mouse red cell (uninfected) ALAD activities
are due to the same protein species.
To further prove that the parasite ALAD is of host red cell
origin, attempts were made to demonstrate that when the host
red cell ALAD is inhibited irreversibly by succinylacetone, the
parasite (P. falciparum) cultured with such RBCs also acquires
the inhibited enzyme. First, it was found that while the para-
site cultured in control RBCs had a detectable ALAD activity,
the activity was too low to be detected in parasites derived from
succinylacetone-treated RBCs. This was further substantiated
by measuring [4-14C]ALA incorporation into heme in the par-
asite and IRS fractions. The results presented in Table III
indicate that incorporation of [4-14C]ALA into heme in the
parasite and IRS fractions derived from succinylacetone-
treated RBCs is around 10% of the corresponding fractions
derived from control RBCs. ALAD activity assays from control,
succinylacetone-treated, and mixed RBC lysates indicate that
there is no free succinylacetone left to inhibit the enzyme
activity or heme synthesis in the parasite (Table IV). It has also
been noted that the parasitemia tends to fall when the parasite
is cultured in succinylacetone treated RBCs, and there is a
striking inhibition of parasite growth after three or four sub-
culturings with such RBCs, indicating that the level of ALAD
in the parasite is too low to sustain an optimal rate of de novo
heme synthesis to support growth.
Parasite (P. berghei) ALAD Is Not a Contaminant from the
Host—First, the parasite fraction used to assay or purify ALAD
was thoroughly washed, till the washings did not carry a de-
tectable enzyme activity. Second, the parasite membrane frac-
tion as isolated after lysis of the intact parasite does not con-
tain detectable ALAD enzyme activity or the protein species
detectable by Western analysis under conditions where the
activity can be demonstrated in the parasite cytosol fraction.
Third, the recoveries of ALAS, ALAD, CPO, and FC proteins in
the parasite do not follow the trend seen in the RBC superna-
tant (Fig. 6). Further, to rule out the presence of ALAD in the
parasite fraction as an experimental contaminant, in situ im-
munogold labeling of the enzyme was carried out with the
isolated parasite as well as with the infected red cell. In both
FIG. 2. SDS-PAGE profile of purified ALAD from P. berghei.
The enzyme was purified from P. berghei as described under “Experi-
mental Procedures.” The purified preparation was analyzed on SDS-
PAGE (10% polyacrylamide gel). Lane 1, molecular weight markers;
lane 2, purified ALAD.
FIG. 3. Western blot analysis and N-terminal sequence of pu-
rified ALAD from P. berghei and uninfected mouse RBC. A,
Western blot was carried out with antibodies to purified ALAD from
human RBC. 75 ng of purified protein was analyzed by SDS-PAGE (10%
polyacrylamide gel). M, mouse RBC; P, parasite. B, sequence of 20
amino acids at the N terminus of purified ALAD from P. berghei and
mouse RBC.
TABLE II
ALAS, ALAD, and FC activities in isolated fractions from infected
(P. berghei) and uninfected red cells
The parasite pellet, IRS, and URS fractions were isolated as de-
scribed earlier. ALAS and FC were assayed in the membrane fraction
(8000 3 g pellet). ALAD was assayed in the soluble fraction after
fractionation through DEAE-Sepharose to remove hemoglobin. The as-
say conditions are given under “Experimental Procedures.” The values
represent mean 6 S.D. obtained from three different experiments.
Enzyme activity
ALASa ALADb FCc
Parasite 0.130 6 0.008 0.074 6 0.006 1.17 6 (0.09 3 107)
IRS 0.040 6 0.012 3.879 6 1.023 8.89 6 (0.81 3 106)
URS 0.039 6 0.008 0.442 6 0.058 1.16 6 (0.06 3 106)
a Values for ALAS are in mmol of PBG equivalent/mg of protein.
b Values for ALAD are in mmol of PBG/mg of protein.
c Values for FC are cpm in heme/mg of protein.
TABLE III
[4-14C]ALA incorporation into heme in P. falciparum culture
maintained on SA-treated RBCs
The experimental details are given under “Experimental Proce-
dures.” The parasite was cultured in untreated (control) and SA-treated
RBCs. The final culture (1.5 ml) was incubated with 1 mCi of [4-14C]ALA
overnight, and radioactivity incorporated into the heme fraction iso-
lated from the parasite and red cell supernatant was measured. The
results presented are those obtained in a typical experiment.
Fraction Radioactivity in heme
cpm/1.5 ml culture
Parasite (control RBC) 375
Parasite (SA-treated RBC) 45
RBC supernatant (control) 11,400
RBC supernatant (SA-treated) 1200
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cases, immunoelectron microscopy indicates that the grains are
seen inside the parasite and not on the periphery, supporting
the possibility of import of the host enzyme into the parasite
and ruling out experimental contamination (Fig. 4). It is also
interesting to note that the infected red cell has many more
grains than the uninfected red cell, confirming the enzyme
activity model presented in Table II.
Parasite (P. berghei) Membrane Specifically Binds Host Red
Cell ALAD—To examine whether a possible receptor for host
red cell ALAD could exist on the parasite membrane, partially
purified ALAD from the red cell was incubated with parasite
membrane fraction for 1 h at 25 °C, and the membrane fraction
was reisolated, washed thoroughly, and then analyzed for
ALAD protein by Western analysis after SDS-PAGE. The re-
sults presented in Fig. 5A indicate that the parasite membrane
can specifically bind to host red cell ALAD. Under identical
conditions, the red cell membrane has no sites for binding the
protein. Incubation of the parasite membrane with bacterially
expressed mammalian glutathione S-transferase and glutathi-
one S-transferase-retinoic acid X receptor fusion protein does
not lead to detectable binding of these proteins. Trypsinized
and washed parasite membrane fails to bind ALAD (Fig. 5B,
lanes 3–5). The ALAD protein can be recovered in the super-
natant fraction, suggesting that the failure to detect membrane
binding is not due to degradation of ALAD by leftover trypsin.
Finally, the parasite membrane incubated with partially pure
ALAD was reisolated, washed, and subjected to immunoelec-
tron micrography. A specific association of the enzyme with the
parasite membrane can be clearly demonstrated, while the red
blood cell manifests negligible binding (Fig. 5C).
Attempts were then made to estimate the number of binding
sites for ALAD on the parasite membrane. Initial attempts to
label the native protein using radiolabeled iodine led to some
degradation of the protein and irreproducible binding data.
Therefore, the mouse erythroid ALAD was expressed in E. coli
and biosynthetically labeled with [35S]methionine. Since the
protein was expressed with a histidine tag, it could be purified
on a nickel-nitrolotriacetic acid column. Once again, binding
experiments with intact parasite membrane gave high back-
ground, perhaps due to difficulty in effective washing of the
membrane by centrifugation. Therefore, binding of 35S-labeled
ALAD to solubilized parasite membrane loaded on to nitrocel-
lulose membrane filters was carried out. This approach gave
reproducible results, and the binding of radioactive ALAD
could be chased by the nonradioactive species to an extent of
85–90%. The binding of ALAD to NC filters in the absence of
parasite membrane preparation was negligible. The saturation
curve and the Scatchard plot are given in Fig. 6 (A and B). The
nonspecific binding was deducted to generate the Scatchard
plot. The data indicate a fairly high affinity of binding (disso-
ciation constant, 6.3 6 0.4 3 1029) with the number of binding
sites estimated at 1550 6 26/parasite.
Western Blot Analysis of ALAS, ALAD, CPO, and FC in
Parasite, IRS, and URS—Western analysis of ALAS, CPO, and
FC in the membrane fractions of the parasite, IRS, and URS
reveals interesting features (Fig. 7). First, antibodies to human
erythroid ALAS do not cross-react with the parasite enzyme,
although the mouse red cell membrane preparation shows a
strong cross-reaction (;72 kDa). However, the membrane prep-
aration used actually shows 3–4-fold more ALAS enzyme spe-
cific activity in the parasite than in the mouse red cell. CPO is
hardly detectable in the parasite and URS, although strikingly
large amounts are seen in IRS (;37 kDa). Separate experi-
ments reveal that when more protein is loaded on gels, the
parasite CPO can be shown to move with a mobility identical to
that of the host CPO, both cross-reacting with antibodies to the
FIG. 4. Immunogold electron microscopy of P. berghei trophozoites and infected and uninfected red cells. The isolated parasite as
well as the red blood cells were processed as described in the text. The preparations were incubated with ALAD antibodies and then treated with
anti-rabbit IgG conjugated to gold particles. A, isolated parasite; B, parasite inside the red cell. Arrow indicates parasite boundary. C, a field of
uninfected red cell. D, A field of infected red cell.
TABLE IV
ALAD activity in untreated and SA-treated RBCs used to culture
P. falciparum
RBCs were treated with SA (500 mM) and then washed with PBS and
ALA to remove free SA as described under “Experimental Procedures.”
ALAD activity was assayed in the red cell lysates. The results represent
mean 6 S.D. obtained from three different experiments.
Fraction ALAD activity
mmol PBG/mg protein
RBC (untreated control) 0.390 6 0.048
RBC (SA-treated) 0.003 6 0.001
Untreated plus treated 0.381 6 0.052
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human enzyme (data not presented). FC protein levels in the
parasite and IRS are about the same, with only traces detected
in URS. Once again, the protein preparations from all three
preparations have identical mobilities in SDS gels (;42 kDa)
and cross-react with antibodies to the human enzymes.
The almost equal FC enzyme activity detected in the parasite
and IRS (Table II) correlates with the Western blot analysis
(Fig. 7). ALAD protein was analyzed in the soluble fraction.
The bulk of the protein is seen in the IRS with lower levels in
URS and parasite (Fig. 7). This result also correlates well with
the enzyme activity pattern shown in Table II.
DISCUSSION
The present study on the localization of the enzymes of the
heme-biosynthetic pathway in the malarial parasite indicates a
dual origin for these proteins. The first enzyme of the pathway,
namely ALAS, is detectable in the parasite membrane at a
level significantly higher than that of the host red cell mem-
brane in terms of activity. However, the parasite enzyme, un-
like that of the host red cell enzyme, does not cross-react with
antibodies against human erythroid ALAS. This suggests the
parasite origin of the ALAS localized in the parasite mem-
brane. This suggestion is supported by a recent report on the
successful cloning of the ALAS gene from P. falciparum (24).
Parasite ALAD, CPO, and FC fall into another category. These
are induced in the host (mice) in response to parasite (P.
berghei) infection, and an amount is then perhaps translocated
into the parasite.
Interestingly, there is no induction of ALAS in the IRS, once
FIG. 5. Binding of ALAD to parasite membrane. Binding of par-
tially purified ALAD to parasite membrane, red cell membrane, and
trypsin-treated parasite membrane was assessed by Western blot anal-
ysis as described under “Experimental Procedures.” Binding of bacte-
rially expressed GST and GST-RXR to the parasite membrane was
assessed similarly using GST-RXR antibodies. A, binding of ALAD,
GST, and GST-RXR to parasite and red cell membranes. 1 and 2 refer
to the data obtained with and without the purified proteins, respec-
tively, added to the incubation mixtures with the membrane prepara-
tions. The first and last lanes (left to right) indicate the migration of the
purified proteins, ALAD and GST plus GST-RXR, detected using the
respective antibodies. B, binding of ALAD to trypsin-treated parasite
membrane. Lane 1, no protein addition; lane 2, ALAD binding to mem-
brane without trypsin treatment; lanes 3–5, incubation of ALAD with
the trypsin-treated membrane preparations. The membrane prepara-
tions were pretreated with 50 ng of trypsin at 30 °C for 10, 15, and 30
min, respectively. C, immunogold electron micrograph of parasite mem-
brane and RBC incubated with ALAD. The conditions for incubation
were as described under “Experimental Procedures.”
FIG. 6. Binding of ALAD to parasite (P. berghei) membrane.
Mouse erythroid ALAD was expressed in E. coli and biosynthetically
labeled with [35S]methionine. Purified ALAD (1.06 3 105 cpm/mg of
protein) was incubated with 2.4 mg of solubilized parasite membrane
protein (4.2 3 107 parasites), and binding was measured using the
nitrocellulose filter binding assay. A, saturation curve with increasing
concentrations of ALAD. Binding was carried out in the absence (l) and
presence (f) of a 100-fold excess of nonradioactive ALAD. B, Scatchard
plot derived from data given in A. The nonspecific binding was deducted
at each concentration of the enzyme used. This plot was used to calcu-
late the dissociation constant and the number of binding sites. The
molecular mass for the octomeric protein was taken as 336 kDa.
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again indicating a difference in its origin in the parasite. Pre-
liminary studies reveal that in P. falciparum maintained in
culture, there is no significant increase in ALAD in the IRS,
unlike the situation seen in mice with P. berghei infection in
vivo. This is to be expected, since the erythrocytes used to
culture P. falciparum represent a terminally differentiated
state and are incapable of RNA or protein synthesis. Therefore,
the higher level of heme synthesis in parasite-infected cultures
of P. falciparum should be due to the contribution of ALAS and
perhaps FC from the parasite. The high levels of ALAD, CPO,
and FC detected in P. berghei-infected mouse erythrocytes
should be related to induction of these enzymes during the red
cell maturation in vivo, perhaps due to stimulus provided by
parasite-mediated red cell degeneration.
Detailed studies with ALAD reveal that the parasite (P.
berghei) enzyme is identical to that of the host red cell but is not
a contaminant. The immunogold labeling experiments and the
demonstration of specific binding of host red cell ALAD to
isolated parasite membrane suggest that this enzyme from the
host may be translocated into the parasite through a receptor.
These studies indicate that the host ALAD binds to the para-
site membrane with high affinity, with the number of binding
sites coming to about 1550/parasite. This can only be consid-
ered as a minimal estimate, since the binding studies have
been carried out with solubilized membrane for reasons men-
tioned earlier.
A similar mechanism of translocation from the host may also
operate, in the cases of CPO and FC, on the basis that these
enzymes from the parasite have identical mobilities on SDS-
PAGE with those of the host and that the parasite and host
enzymes cross-react with antibodies to the human erythroid
species, although further studies are needed to establish this
point. However, unlike in the case of ALAD and CPO, the
parasite has significantly high levels of FC. In mammalian
mitochondria, both ALAS and FC, the first and last enzymes of
the heme-biosynthetic pathway, are localized in the inner mi-
tochondrial membrane (25). There is a possibility that FC like
ALAS may also be coded for by the parasite genome, or it may
be of dual origin.
While there is extensive literature on the transport of pro-
teins made by the parasite into the host erythrocyte (20, 26,
27), internalization of host hemoglobin and its degradation in
parasite food vacuoles lead to generation of amino acids for
parasite protein synthesis and large amounts of heme, detoxi-
fied and stored as inert hemozoin pigment. Superoxide dis-
mutase represents another example, where 20% of the activity
in the parasite is accounted for by the parasite gene coding for
the protein and the rest is accounted for by the host red cell
superoxide dismutase internalized by the parasite. However,
the adopted superoxide dismutase has not been proven to par-
ticipate functionally in the parasite (28, 29). In the case of
ALAD, it is clear that the entire functional enzyme of the
parasite is derived from the host. Besides, it has not so far been
possible to identify the ALAD gene in the parasite genome
(studies in this laboratory), although this cannot be taken as an
evidence for its absence.
The results obtained with [4-14C]ALA incorporation into
heme in cultures of P. falciparum and P. berghei indicate that
80% of the radioactivity is recovered in IRS. This correlates
well with the higher levels of ALAD and the subsequent en-
zymes in IRS than in the parasite. In contrast to this situation,
the results obtained with [2-14C]glycine incorporation into
heme clearly indicate that 80% of the radioactivity is recovered
in the parasite fraction. This suggests that this precursor is
essentially handled by ALAS in the parasite membrane and
that the level of this enzyme is also significantly higher than
that of the red cell membrane enzyme. The results also indicate
that there is no significant loss of the intermediates from the
parasite into the IRS, or perhaps import of the intermediates
from IRS into the parasite also does not take place. The para-
site has evolved a mechanism to import the required enzymes
rather than the biosynthetic intermediates or preformed heme.
Heme should be essentially synthesized within the mitochon-
drion of the parasite, as is the case with mammalian mitochon-
dria, and then distributed to the other parasite compartments.
Thus, the parasite has evolved a strategy to segregate and
divert the heme derived from red cell hemoglobin into the inert
hemozoin pigment while making use of the heme synthesized
de novo for metabolic purposes.
These studies have also identified new potential drug tar-
gets. These would be ALAS species unique to the parasite and
the receptor(s) on the parasite membrane to import ALAD and
perhaps the other enzymes of the pathway from the host. It
would also be of interest to examine in this context whether the
parasite employs additional mechanisms for making ALA.
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